Jonathan Sporn Founder of Gilgamesh Pharmaceuticals Backed byPalo Santo FundDaniel Goldberg LinkedIn SourcesGilgamesh Pharma Announces Positive Topline Phase 2a Results for Blixeprodil (GM-1020) in Major Depressive Disorder — 2022-12 Browse all founders · Browse investors
